Day 2 | Unlocking the Research Pipeline: Trials & Real-World Genomics | #BIOMARKERS26

As comprehensive genomic profiling (CGP) moves toward standard of care, attention is shifting from generating genomic data to understanding how it can improve decision-making across the cancer system. This session examines how clinical trials, real-world genomic data, and coordinated research infrastructure can strengthen Canada's precision oncology ecosystem, particularly where traditional evidence pathways fall short. Experts discuss: • Gaps in clinical trial inclusion for metastatic cancer patients eligible for CGP • The role of real-world genomic data in informing patient-centred policy and system decision-making • How national genomic repositories and data-sharing platforms can support a coordinated research strategy • Collaborative research models that integrate CGP into clinical and translational studies Moderator: Dr. Stéphanie Michaud — President and CEO, BioCanRx Patient Perspective: Dillan Eisenhaur — Founder, Second Look Cancer Inc. Panelists: Dr. Yvonne Bombard (Unity Health Toronto / U of T), Dr. Jim Woodgett (Terry Fox Research Institute), Dr. Arvind N. Dasari (MD Anderson Cancer Center, USA) This session was recorded during CCRAN's 2026 Biomarkers Conference (June 18–19, 2026), a national event bringing together clinicians, researchers, policy professionals, patients, and caregivers to advance a coordinated strategy for comprehensive genomic profiling in Canada. Learn more about CCRAN: https://ccran.org Explore more Biomarkers Conference sessions:    • 2026 Biomarkers Conference | #BIOMARKERS26